Free Trial

Nutrien (NTR) Stock Price, News & Analysis

$46.33
-0.18 (-0.39%)
(As of 09/6/2024 ET)
Today's Range
$46.04
$46.90
50-Day Range
$45.89
$52.20
52-Week Range
$44.90
$65.00
Volume
2.09 million shs
Average Volume
1.91 million shs
Market Capitalization
$22.92 billion
P/E Ratio
27.09
Dividend Yield
4.66%
Price Target
$63.78

Nutrien MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.53 Rating Score
Upside/​Downside
37.7% Upside
$63.78 Price Target
Short Interest
Healthy
0.98% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-5.10
Upright™ Environmental Score
News Sentiment
1.18mentions of Nutrien in the last 14 days
Based on 8 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
3.98%
From $3.77 to $3.92 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.92 out of 5 stars

Basic Materials Sector

5th out of 180 stocks

Agricultural Chemicals Industry

1st out of 11 stocks

NTR stock logo

About Nutrien Stock (NYSE:NTR)

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products. The Nitrogen segment offers ammonia, urea, environmentally smart nitrogen, nitrogen solutions, nitrates, and sulfates. The Phosphate segment provides solid fertilizer, liquid fertilizer, and industrial and feed products. In addition, it provides services directly to growers through a network of farm centers in North America, South America, and Australia. The company is headquartered in Saskatoon, Canada.

NTR Stock Price History

NTR Stock News Headlines

Nutrien (NYSE:NTR) Stock Quotes, Forecast and News Summary
Ex-CIA Advisor: “This is How Kamala will Rig the Election”
A former CIA advisor with close ties to the White House… Has just released this shocking expose on Kamala’s plan to stop Trump. Every American needs to prepare now…
Nutrien Target of Unusually Large Options Trading (NYSE:NTR)
Analysts Set Nutrien Ltd. (NYSE:NTR) PT at $63.78
NTR Aug 2024 43.000 call
Ex-CIA Advisor: “This is How Kamala will Rig the Election”
A former CIA advisor with close ties to the White House… Has just released this shocking expose on Kamala’s plan to stop Trump. Every American needs to prepare now…
Nutrien Remains A 'Strong Buy' As The Tide Is Turning
Nutrien Ltd. (NTR)
NTR Sep 2024 30.000 put
NTR Aug 2024 54.000 put (NTR240816P00054000)
See More Headlines
Receive NTR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nutrien and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 7/19 Dividend
6/28/2024
Dividend Payable
7/19/2024
Last Earnings
8/07/2024
Today
9/07/2024
Ex-Dividend for 10/18 Dividend
9/27/2024
Dividend Payable
10/18/2024
Next Earnings (Estimated)
11/06/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Agricultural chemicals
Sub-Industry
Chemicals
Employees
25,900
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$63.78
High Stock Price Target
$78.00
Low Stock Price Target
$48.00
Potential Upside/Downside
+37.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.53
Research Coverage
19 Analysts

Profitability

Net Income
$1.26 billion
Pretax Margin
4.40%

Debt

Sales & Book Value

Annual Sales
$26.84 billion
Cash Flow
$8.47 per share
Book Value
$50.96 per share

Miscellaneous

Free Float
479,403,000
Market Cap
$22.92 billion
Optionable
Optionable
Beta
0.82

Social Links

The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

  • Mr. Kenneth A. SeitzMr. Kenneth A. Seitz (Age 54)
    President, CEO & Director
    Comp: $1.63M
  • Mr. Pedro FarahMr. Pedro Farah
    Executive VP & CFO
  • Ms. Noralee M. Bradley LLB.
    Executive VP of External Affairs and Chief Sustainability & Legal Officer
  • Mr. Jeffrey Martin Tarsi
    Executive VP & President of Global Retail
  • Mr. Christopher Pringle Reynolds (Age 50)
    Executive VP & President of Potash
    Comp: $947.05k
  • Jeff Holzman
    Vice President of Investor Relations
  • Megan Fielding
    VP of Brand & Culture Communications
  • Mr. Andrew J. Kelemen
    Executive VP of Corporate Development & Chief Strategy Officer
  • Jason Newton
    Head Economist
  • Mr. Mark Thompson
    Executive VP & Chief Commercial Officer

Should I Buy Nutrien Stock? NTR Pros and Cons Explained

Pros

Here are some ways that investors could benefit from investing in Nutrien Ltd.:

  • Nutrien's stock price is currently at $45.89, potentially offering a good entry point for investors looking for value opportunities.
  • Nutrien has a diverse business model with segments in Retail, Potash, Nitrogen, and Phosphate, providing exposure to different aspects of the agricultural industry.
  • The company reported earnings per share of $2.34 for the last quarter, beating analysts' estimates, indicating strong financial performance.
  • Institutional investors and hedge funds have shown interest in Nutrien, with significant purchases of the company's shares, reflecting confidence in its future prospects.
  • Nutrien's dividend yield of 4.71% can be attractive to income-oriented investors seeking regular returns.

Cons

Investors should be bearish about investing in Nutrien Ltd. for these reasons:

  • Market analysts have issued sell ratings for Nutrien's stock, indicating some concerns about its performance and outlook.
  • The company's revenue was down 12.9% compared to the same quarter last year, suggesting potential challenges in revenue growth.
  • Despite a moderate buy rating, the average price target of $64.50 is below the current stock price, signaling limited upside potential according to analysts.
  • Nutrien's debt-to-equity ratio of 0.37 may raise concerns about its leverage and financial stability, impacting investor confidence.
  • The company's stock has been trading below its 50-day and 200-day simple moving averages, indicating a possible bearish trend in the short to medium term.
These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, August 19, 2024. Please send any questions or comments about these Nutrien pros and cons to contact@marketbeat.com.

NTR Stock Analysis - Frequently Asked Questions

How have NTR shares performed this year?

Nutrien's stock was trading at $56.33 on January 1st, 2024. Since then, NTR stock has decreased by 17.8% and is now trading at $46.33.
View the best growth stocks for 2024 here
.

How were Nutrien's earnings last quarter?

Nutrien Ltd. (NYSE:NTR) posted its earnings results on Wednesday, August, 7th. The company reported $2.34 EPS for the quarter, beating analysts' consensus estimates of $2.19 by $0.15. The company's revenue was down 12.9% on a year-over-year basis.

Who are Nutrien's major shareholders?

Nutrien's top institutional investors include Mackenzie Financial Corp (2.71%), Bank of Montreal Can (2.70%), First Eagle Investment Management LLC (1.92%) and 1832 Asset Management L.P. (1.82%).

How do I buy shares of Nutrien?

Shares of NTR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Nutrien own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Nutrien investors own include AT&T (T), Pfizer (PFE), Johnson & Johnson (JNJ), General Electric (GE), Intel (INTC), Bank of America (BAC) and CVS Health (CVS).

This page (NYSE:NTR) was last updated on 9/7/2024 by MarketBeat.com Staff

From Our Partners